Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

被引：0
|
作者：
Sara Simonetti
Miguel Angel Molina
Cristina Queralt
Itziar de Aguirre
Clara Mayo
Jordi Bertran-Alamillo
José Javier Sanchez
Jose Luis Gonzalez-Larriba
Ulpiano Jimenez
Dolores Isla
Teresa Moran
Santiago Viteri
Carlos Camps
Rosario Garcia-Campelo
Bartomeu Massuti
Susana Benlloch
Santiago Ramon y Cajal
Miquel Taron
Rafael Rosell
机构：
[1] USP Dexeus University Institute,Pangaea Biotech
[2] Catalan Institute of Oncology,undefined
[3] Hospital Germans Trias i Pujol,undefined
[4] Autonomous University of Madrid,undefined
[5] Hospital San Carlos,undefined
[6] Hospital La Princesa,undefined
[7] Hospital Lozano Blesa,undefined
[8] Hospital General de Valencia,undefined
[9] Hospital Juan Canalejo,undefined
[10] Hospital General de Alicante,undefined
[11] Hospital Vall d'Hebron,undefined
来源：
Journal of Translational Medicine | / 8卷
关键词：
Epidermal Growth Factor Receptor; NSCLC Patient; Epidermal Growth Factor Receptor Mutation; Epidermal Growth Factor Receptor Gene; Epidermal Growth Factor Receptor TKIs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Classification of atypical EGFR mutations in non-small-cell lung cancer
    Rosell, R.
    Cardona, A. F.
    Arrieta, O.
    Gonzalez-Cao, M.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (06) : 571 - 573
  • [32] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    Kobayashi, S
    Boggon, TJ
    Dayaram, T
    Janne, PA
    Kocher, O
    Meyerson, M
    Johnson, BE
    Eck, MJ
    Tenen, DG
    Halmos, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 786 - 792
  • [33] Concomitant Driver Mutations in Advanced Stage Non-Small-Cell Lung Cancer of Adenocarcinoma Subtype with Activating EGFR-Mutation
    Sorensen, Jens Benn
    Grauslund, Morten
    Melchior, Linea
    Jakobsen, Jan
    Santoni-Rugiu, Eric
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S518 - S519
  • [34] A diagnostic algorithm using EGFR mutation-specific antibodies for rapid response EGFR-TKI treatment in patients with non-small cell lung cancer
    Kawahara, Akihiko
    Taira, Tomoki
    Azuma, Koichi
    Tominaga, Masaki
    Hattori, Satoshi
    Kawahara, Mayuko
    Abe, Hideyuki
    Yamaguchi, Tomohiko
    Akiba, Jun
    Takamori, Shinzo
    Hayashi, Akihiro
    Kage, Masayoshi
    [J]. LUNG CANCER, 2012, 78 (01) : 39 - 44
  • [35] Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
    Rosell, Rafael
    Aguilar-Hernandez, Andres
    Gonzalez-Cao, Maria
    [J]. CANCERS, 2023, 15 (09)
  • [36] Depression and EGFR mutation status in stage IV non-small cell lung cancer.
    Pirl, W. F.
    Greer, J.
    Bemis, H.
    Heist, R. S.
    Gallagher, E.
    Sequist, L. V.
    Engelman, J. A.
    Traeger, L.
    Lennes, I. T.
    Temel, J. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Palliative resection for stage IV non-small-cell lung cancer
    Swatek, Paul
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (19-20) : 772 - 772
  • [38] Chemoimmunotherapy for stage IV non-small-cell lung cancer Reply
    Cappuzzo, Federico
    West, Howard
    [J]. LANCET ONCOLOGY, 2019, 20 (09): : E467 - E467
  • [39] Challenges of Immunotherapy in Stage IV Non-Small-Cell Lung Cancer
    Stock-Martineau, Sophie
    Magner, Kate
    Jao, Kevin
    Wheatley-Price, Paul
    [J]. JCO ONCOLOGY PRACTICE, 2021, 17 (08) : 465 - +
  • [40] Chemotherapy of stage IIIB and IV non-small-cell lung cancer
    Cojean, I
    LeChevalier, T
    [J]. ANNALS OF ONCOLOGY, 1995, 6 : 41 - 44
12345